---
title: HPV
permalink: /hpv/
variant: tiptap
description: ""
third_nav_title: G to L
---
<div data-type="detailGroup" class="isomer-accordion isomer-accordion-white">
<details class="isomer-details">
<summary><strong>Overview/Background</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Human papillomavirus (HPV) is a common sexually transmitted infection
(STI). There are more than 100 subtypes of HPV, which are categorised into
high-risk and low-risk types. Oncogenic, high-risk HPV infection (e.g.,
HPV types 16 and 18) causes the majority of cervical, penile, vulvar, vaginal,
anal, and oropharyngeal cancers and precancers, whereas other HPV infection
(e.g., HPV types 6 and 11) causes genital warts and recurrent respiratory
papillomatosis.</p>
<p>&nbsp;</p>
<p>HPV infection is very common, and most infections do not result in clinically
visible genital tract lesions. Cancers from HPV can be prevented with vaccination.</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>Disease Epidemiology</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>From the data of 2019, it was estimated that 620,000 new cases of cancer
in women and 70,000 in men were attributed to HPV globally. Cervical cancer,
which ranked as the fourth leading cause of cancer and cancer-related deaths
in women in 2022, accounted for approximately 660,000 new cases and around
350,000 deaths worldwide. Cervical cancers make up more than 90% of HPV-related
cancers in women. In Singapore, cervical cancer is the tenth most common
cancer among women.</p>
<p></p>
<p>The highest rates of cervical cancer incidence and mortality are observed
in low- and middle-income countries, underscoring significant disparities
resulting from limited access to national HPV vaccination, cervical screening,
treatment services, and broader social and economic factors. The prevalence
of the virus is higher among women with HIV, men who have sex with men
(MSM), individuals with compromised immune systems, those with co-infections
of other STIs, individuals receiving immunosuppressive medications, and
children who have experienced sexual abuse.</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>Pathogen(s)</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Human papillomavirus (HPV)</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>Transmission</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Transmission can occur during oral, vaginal and anal sex and other intimate
skin-to-skin contact.<sup> </sup>HPV types 6 and 11 are transmitted predominantly
by epithelial contact. HPV can spread even when a person with infection
has no signs or symptoms.</p>
<p>&nbsp;</p>
<p><strong>Incubation period:</strong> 2 to 3 months, with a range of 1 to
20 months for genital warts</p>
<p><strong>Infectious period: </strong>Unknown &nbsp;</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>Clinical Features</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>HPV infection occurs as:</p>
<ul data-tight="true" class="tight">
<li>
<p>Clinical lesions: condylomata acuminata, papular and flat warts</p>
<ul data-tight="true" class="tight">
<li>
<p>condyloma acuminata: exophytic, filiform, cauliflower-shaped warts, HPV
types 6 and 11 in &gt;90% of cases</p>
</li>
<li>
<p>multifocal: usually 5 to 15, in areas of trauma during sex, 1-10 mm diameter,
may coalesce especially in immunosuppressed and in the presence of diabetes
mellitus</p>
</li>
<li>
<p>may be coinfected with oncogenic “high-risk” HPV e.g. types 16 and 18</p>
</li>
<li>
<p>oncogenic HPV: mostly give rise to subclinical lesions, intraepithelial
neoplasia (IN) and anogenital cancer</p>
</li>
</ul>
</li>
<li>
<p>Subclinical lesions: only visible after application of acetic acid and
magnification</p>
</li>
<li>
<p>Latent HPV infection defined when HPV DNA can be demonstrated in absence
of clinical or histological evidence of infection</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Risk Factors</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Risk factors include:</p>
<ul data-tight="true" class="tight">
<li>
<p>Onset of sexual intercourse at an early age</p>
</li>
<li>
<p>Unprotected sex or inconsistent condom use if the relationship is not
monogamous</p>
</li>
<li>
<p>Having multiple sex partners</p>
</li>
<li>
<p>Persons who exchange sex for money or drugs</p>
</li>
<li>
<p>Past history or current presence of other STIs</p>
</li>
<li>
<p>Long term consumption of combined oral contraceptive pills</p>
</li>
<li>
<p>Smoking</p>
</li>
<li>
<p>Immunosuppression (innate or acquired), including HIV infection</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Diagnosis</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>A clinical diagnosis is made from recognition of characteristic lesions.</p>
<ul data-tight="true" class="tight">
<li>
<p>Subclinical mucosal warts can be identified by turning white (acetowhite)
after application of 5% acetic acid for 3 minutes. This can be applied
onto discrete as well as suspected sub-clinical lesions; the mechanism
for this aceto-whitening effect is not clear. One hypothesis is that acetic
acid causes a reversible coagulation of some epithelial and stromal proteins.
Note that this whitening effect may also occur in areas of abrasions or
non-specific inflammation, and may also be seen in other infections such
as candidiasis, and thus is not specific for HPV infection.</p>
</li>
<li>
<p>Skin biopsy is indicated for atypical cases, cases where the benign nature
of papular or macular lesions is unclear. Features which may raise suspicion
include pigmentation, depigmentation, pruritus, immune-deficiency and prior
history of intraepithelial neoplasia. Biopsy may also be indicated when
the lesions do not respond to standard therapy, or worsen during therapy.</p>
</li>
<li>
<p>If a clinical diagnosis has been made, HPV testing is not recommended
to confirm anogenital wart diagnosis.</p>
</li>
<li>
<p>Screening for HPV in females can be found in the <a href="https://www.ams.edu.sg/view-pdf.aspx?file=media%5c4817_fi_59.pdf&amp;ofile=STRC+Report+March+2019.pdf" rel="noopener noreferrer nofollow" target="_blank">national guidelines.</a>
</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Treatment and Management</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Treatment is directed to the macroscopic (e.g., genital warts) or pathologic
precancerous lesions caused by HPV. While subclinical genital HPV infection
typically clears spontaneously, treatment can be given to remove visible
exophytic warts. No treatment, however, is completely satisfactory in eliminating
HPV infection.</p>
<p>&nbsp;</p>
<p>It is important to perform meatoscopy for meatal warts, proctoscopy for
anal warts, and speculum examination with cervical cytology/colposcopy
for female genital warts.</p>
<p>&nbsp;</p>
<p>Precancerous lesions are detected through cervical cancer screening; HPV-related
precancer should be managed on the basis of the national guidelines.</p>
<p>&nbsp;</p>
<p>Follow-up:</p>
<ul data-tight="true" class="tight">
<li>
<p>Provide clear information: causes, treatment, outcomes, and possible complications.</p>
</li>
<li>
<p>Advise smoking cessation for recalcitrant warts</p>
</li>
<li>
<p>Regular cervical cytology (PAP smears) for females</p>
</li>
<li>
<p>·Condoms: with new partners till clearance is achieved; regular partner
already exposed.</p>
</li>
<li>
<p>Long latency periods mean that only one partner in a relationship may
manifest warts.</p>
</li>
<li>
<p>Current partners and recent partners within 6 months should be assessed
for HPV and other STI</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Precaution, Prevention and Control</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>All women who have ever had sex should undergo screening for cervical
cancer from the age of 25. According to the national cancer screening guidelines,
the recommended screening interval is as follows:</p>
<ul data-tight="true" class="tight">
<li>
<p>Age 25 – 29 years: pap smear screening once every 3 years. Primary HPV
testing is not recommended for women in this age group</p>
</li>
<li>
<p>Age 30 – 69 years: HPV testing once every 5 years</p>
</li>
</ul>
<p>&nbsp;</p>
<p>Prevention of HPV:</p>
<ul data-tight="true" class="tight">
<li>
<p>Not having sex</p>
</li>
<li>
<p>Consistent and correct use of condoms when engaging in sexual activity&nbsp;</p>
</li>
<li>
<p>Limit the number of sex partners</p>
</li>
<li>
<p>Undergo cervical cancer screening regularly</p>
</li>
<li>
<p>HPV vaccines are recommended to all females between the ages of 9 and
26 years.</p>
<ul data-tight="true" class="tight">
<li>
<p>Three HPV vaccines are available for the prevention of HPV infection:</p>
<ul data-tight="true" class="tight">
<li>
<p>A bivalent vaccine (Cervarix), which protects against HPV types 16 and
18</p>
</li>
<li>
<p>A quadrivalent vaccine (Gardasil-4), which protects against types 6, 11,
16 and 18.</p>
</li>
<li>
<p>A 9-valent vaccine (Gardasil-9), which protects against types 6, 11, 16,
18, 31, 33, 45, 52 and 58.</p>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<p>&nbsp;</p>
<p>Management of sexual contacts:</p>
<ul data-tight="true" class="tight">
<li>
<p>Patients should inform current partners about having genital warts because
the types of HPV that cause warts can also be passed on to partners.</p>
</li>
<li>
<p>Partners should be counselled that they might already have HPV despite
no visible signs of warts; therefore, HPV testing of sex partners of persons
with genital warts is not recommended.</p>
</li>
<li>
<p>Partners might benefit from a physical examination to detect genital warts
and tests for other STIs.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
</li>
<li>
<p>No recommendations can be made regarding informing future sex partners
about a diagnosis of genital warts because the duration of viral persistence
after resolution of warts is unknown.</p>
</li>
</ul>
</div>
</details>
<details class="isomer-details">
<summary><strong>Notification</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>HPV is not a notifiable disease.</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>Resources</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<p>Please refer to <a href="https://www.ams.edu.sg/view-pdf.aspx?file=media%5c4817_fi_59.pdf&amp;ofile=STRC+Report+March+2019.pdf" rel="noopener noreferrer nofollow" target="_blank">Academy of Medicine Singapore</a> for
information on cervical cancer screening.</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>Please refer to <a href="https://www.nsc.com.sg/dsc/healthcare-professionals/publications/Pages/STI-Management-Guidelines.aspx" rel="noopener noreferrer nofollow" target="_blank">DSC’s website</a> for
more information on HPV.</p>
</div>
</details>
<details class="isomer-details">
<summary><strong>References</strong>
</summary>
<div data-type="detailsContent" class="isomer-details-content">
<ul data-tight="true" class="tight">
<li>
<p>Academy of Medicine, Singapore. Report of the Screening Test Review Committee.
2019.</p>
</li>
<li>
<p>Centers for Disease Control and Prevention. STI treatment guidelines:
Human Papillomavirus (HPV) infections. 2021.</p>
</li>
<li>
<p>Department of Sexually Transmitted Infections Control (DSC). STI management
guidelines 7<sup>th</sup> edition. 2021.</p>
</li>
<li>
<p>World Health Organization. Human papillomavirus and cancer. 2023.</p>
</li>
</ul>
</div>
</details>
</div>
<p></p>